ETFs

KraneShares MSCI All China Health Care Index ETF

KURE:PCQ:USD

KraneShares MSCI All China Health Care Index ETF

Actions
  • Price (USD)15.19
  • Today's Change-0.12 / -0.78%
  • Shares traded26.92k
  • 1 Year change-26.55%
Data delayed at least 15 minutes, as of May 03 2024 21:10 BST.
More ▼
Find Funds and ETFs
Find Funds and ETFs
Use our fund screener to discover other asset types.
 
Funds ScreenerGo to the Funds Screener

Asset allocation

Distribution

Type% Net assets% Short% Long
Non-US stock97.12%0.00%97.12%
US stock2.76%0.00%2.76%
Cash0.12%0.00%0.12%
US bond0.00%0.00%0.00%
Non-US bond0.00%0.00%0.00%
Other0.00%0.00%0.00%
As of Apr 30 2024

Weightings

Sectors
Equity
Fixed income
Sector% Net assetsCategory average
Healthcare94.97%5.93%
Consumer Defensive1.12%7.58%
Basic Materials0.69%2.42%
Consumer Cyclical0.00%22.12%
Other0.00%18.20%
Communication Services0.00%16.98%
Financial Services0.00%15.85%
Industrials0.00%5.89%
Real Estate0.00%3.10%
Energy0.00%1.93%
As of Apr 30 2024. Sectors weighting is calculated using only long position holdings of the portfolio.

Top 10 holdings

Top 10 holdings as a per cent of portfolio
36.32%42.45%0.00%42.45%
Category average% Net assets% Short% Long
Company1 year changePortfolio weightLong allocation
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A-0.58%8.57%
Jiangsu Hengrui Pharmaceuticals Co Ltd
600276:SHH
-4.34%6.74%
Beigene Ltd
BEIGF:PKC
--4.63%
CSPC Pharmaceutical Group Ltd
1093:HKG
-15.99%4.15%
WuXi Biologics (Cayman) Inc
WXIBF:PKC
--3.78%
Innovent Biologics Inc
IVBXF:PKC
+12.68%3.33%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Class A--3.32%
Aier Eye Hospital Group Co Ltd Class A--2.79%
Wuxi AppTec Co Ltd Class A--2.60%
SHANGHAI UNITE-A--2.54%
Per cent of portfolio in top 10 holdings: 42.45%
Data Provided by LSEG
The performance data shown in tables and graphs on this page is calculated in USD of the fund/index/average (as applicable), on a Bid To Bid / Nav to Nav basis, with gross dividends re-invested on ex-dividend date. Past performance is not necessarily a guide to future performance; unit prices may fall as well as rise.
All managed funds data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All data shown on this page, unless noted otherwise is Data Source and Copyright: Morningstar, Inc. 2024
All Rights reserved
© 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
Pricing for ETFs is the latest price and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.